May 2014: Imperial Innovations and SR One lead £850,000 seed financing for Puridify

InnovationsImperial Innovations Group plc (AIM:IVO, ‘Innovations’), the leading technology commercialisation and investment company and S.R.One Ltd, GlaxoSmithKline’s venture capital fund, announce today that they have led, alongside co-investor UCL Business PLC (UCLB), an £850,000 seed financing for Puridify, a newly formed company providing purification solutions for biotherapeutic manufacturing.

April 2014: Puridify’s successful Collaborative R&D award program application

TSBCollaborativeR&DUCLBBSRC

Puridify was successful leading this application for a £499,728 Technology-inspired innovation – Biosciences project from the Technology Strategy Board’s Collaborative R&D award program. This will see Puridify and University College London develop and test its platform technology with a series of scale down prototypes with key end users driving forward the technology’s commercialisation. This work is co-funded by the Biotechnology and Biological Sciences Research Council.

February 2014: Puridify’s successful Feasibility Studies award program application

TSBpngFeasability

Puridify was successful leading this application for a £114,362 Sustainable high-value chemical manufacture through industrial biotechnology Technical Feasibility project from the Technology Strategy Board’s Feasibility Studies award program. This will see Puridify apply its platform technology to industrial biocatalysis applications in collaboration with an exciting biocatalysis company, Prozomix Limited.

May 2013: OneStart Competition (Winners)

onestart

A big thank you to the organisers and sponsors of OneStart particularly Oxbridge Biotech Roundtable and SRone for not only selecting Puridify as winners of the inaugural OneStart biotech business plan competition, but for giving us and the other teams the opportunity to develop our ventures on the road to commercial success.